OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
May 25, 2023
Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.
May 24, 2023
The facility is based on a state-of-the-art design concept that allows maximum flexibility for a multi-product, multi-platform offering.
May 16, 2023
Outsourcing collaborations provide insight into the key drivers of market growth.
May 09, 2023
The new portfolio from the acquisition will include contract research organization solutions, contract development and manufacturing organization solutions, and KSM/API solutions.
March 01, 2023
The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.
February 13, 2023
The technology is designed to enable patients to self-inject biologic-based therapies at home instead of a hospital setting.
November 08, 2022
Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.
November 01, 2022
The company is expanding its contract development and manufacturing services for parenteral drugs to global customers.
In this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.
October 31, 2022
The CPHI Annual Report 2022 predicts cash reserves from venture capitalists and private equities will drive expansion in the demand for contract research organizations and contract development and research organizations.